Definition of Y 90 Ibritumomab Tiuxetan

A radioimmunotherapeutic agent consisting of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by the chelator tiuxetan to the radioisotope yttrium-90 (Y 90). yttrium Y 90 ibritumomab tiuxetan binds to and specifically delivers beta radiation to CD20-expressing tumor cells, thereby minimizing the systemic effects of radiation.

Y 90 Ibritumomab Tiuxetan is from the group

Radioimmunoconjugate

Other Names for Y 90 Ibritumomab Tiuxetan

Yttrium Y 90 Ibritumomab Tiuxetan
IDEC Y2B8
IDEC-Y2B8 Monoclonal Antibody
IDEC-Y2B8 monoclonal antibody
Ibritumomab (In2B8/Y2B8 Radiolabeling Kit)
Y 90 Ibritumomab Tiuxetan
Yttrium-90 Ibritumomab Tiuxetan
Yttrium Y90 ibritumomab tiuxetan

Source

NCI Thesaurus License